Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
As of April 22, 2026, it was removed from FDA Category 2, but the FDA's Pharmacy Compounding Advisory Committee will not consider it for the 503A bulks list until the July 23, 2026 meeting
It lowers pro-inflammatory cytokines, reduces immune cell infiltration, and supports the resolution of inflammation
Because tinnitus is a perception disorder, there is currently no objective test to diagnose the condition
What is Neurobion
Its important for the physician to assess the clinical context and adjust the frequency of monitoring as needed
US$ 26.71
US$ 29.28
US$ 27.74
